Bradley L. Campbell, President & CEO: Amicus Therapeutics FOLD Sell · Filed 23/03/03

Trade details

Type: Insider sale
Amount: $202,782.72
Shares · price: 15,456 sh · $13.12 a share
Held after: 841,373 sh
Stock: Amicus Therapeutics FOLD
Person: Bradley L. CampbellPresident & CEO
Trade date: 23/03/01
Filed: 23/03/03
Days to filing: 2 days

Sold 1.8% of holdings

Share of holding sold: 1.8%

Amicus Therapeutics trades, last 26 weeks

What else happened in Amicus Therapeutics around then

Filed or reported within 30 days of the trade day · 23/01/30~23/03/31

Bradley L. Campbell's recent trades

Bradley L. CampbellPresident and CEO
Sell10b5-1 planAmicus Therapeutics
Sell10b5-1 plan
Amicus Therapeutics
FOLD
$322.9K
22,500 sh
$322.9K
Filed 03/04
Traded 03/02
Bradley L. CampbellPresident and CEO
Sell10b5-1 planAmicus Therapeutics
Sell10b5-1 plan
Amicus Therapeutics
FOLD
$1.1M
75,000 sh
$1.1M
Filed 01/22
Traded 01/20
Bradley L. CampbellPresident and CEO
Sell10b5-1 planAmicus Therapeutics
Sell10b5-1 plan
Amicus Therapeutics
FOLD
$846.3K
77,926 sh
$846.3K
Filed 25/12/17
Traded 25/12/15
Bradley L. CampbellPresident and CEO
Sell10b5-1 planAmicus Therapeutics
Sell10b5-1 plan
Amicus Therapeutics
FOLD
$146K
14,587 sh
$146K
Filed 25/12/03
Traded 25/12/01
Bradley L. CampbellPresident and CEO
Sell10b5-1 planAmicus Therapeutics
Sell10b5-1 plan
Amicus Therapeutics
FOLD
$146.5K
14,587 sh
$146.5K
Filed 25/11/26
Traded 25/11/24